PO.PR01.02 · 预防研究

Cold atmospheric plasma prevents and treats oral squamous cell carcinoma via disruption of oncogenic pathways

海报缩略图:Cold atmospheric plasma prevents and treats oral squamous cell carcinoma via disruption of oncogenic pathways
编号 5094 展板 8 时间 4/21 09:00–12:00 区域 Section 37 主讲 Shu-Chun Lin, PhD
分会场 Early Detection and Interception
查看完整资料 下载 PDF 登录后可访问当前开放资料 AACR 官方页面 ↗

作者与单位

Pan Jian-Hua1, Kuo-Wei Chang2, Hsi-Feng Tu2, Shu-Chun Lin1

1Oral Biology, National Yang Ming Chiao Tung University, Taipei, Taiwan,2Dentistry, National Yang Ming Chiao Tung University, Taipei, Taiwan

摘要 Abstract

Oral squamous cell carcinoma (OSCC), which develops through a multistep carcinogenic process, is a major threat to public health. Intercepting OSCC at its early stages or controlling established neoplasms continues to pose a significant clinical challenge. Our previous study demonstrated that cold atmospheric plasma (CAP) represents a promising therapeutic strategy for OSCC. In this study, we further investigated the preventive efficacy of CAP against oral carcinogenesis and characterized the molecular alterations associated with its counteracting effects, using murine cell lines and various in vivo models. In the 4-nitroquinoline 1-oxide (4-NQO)-induced tongue carcinogenesis model, CAP irradiation markedly reduced epithelial thickening and suppressed the expression of tumor markers induced by 4-NQO, especially p63 and SOX2. In syngeneic orthotopic transplants of MOC-L1 and MTCQ1 murine OSCC cell lines, CAP treatment significantly inhibited tumor growth. Notably, residual tumor tissues after treatment remained in a growth-arrested but viable state for up to six weeks. These “resistance-like” tumors exhibited downregulation of oncogenic miRNAs, consistent with findings in human OSCC. Transcriptomic profiling and validation experiments revealed activation of pathways related to epithelial-mesenchymal transition, redox regulation, UV-responses and adipogenesis in these persistent tumors. Similarly, CAP-resistant cell subclones displayed molecular signatures paralleling those of resistant tumors, while targeted abrogation of key effector genes enhanced CAP sensitivity. In summary, CAP exerts a preventive effect in early oral neoplastic progression and suppresses OSCC tumorigenesis. Furthermore, combined inhibition of resistance-associated effectors can potentiate CAP-mediated tumor control. The findings provide mechanistic insight into CAP's preventive and therapeutic potential as a novel strategy for OSCC interception.
利益披露 Disclosure
P. Jian-Hua, None.. K. Chang, None.. H. Tu, None.. S. Lin, None.

在会议检索中打开